|Articles|October 9, 2020

Coronavirus News Roundup: Upcoming MJH COVID-19 Coalition Event, Regeneron and Eli Lilly Request EUA for Antibody Therapies

Here's the roundup for this week's coronavirus-related news.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 36,349,500 individuals worldwide, and approximately 7.5 million Americans. The latest COVID-19 related news includes the upcoming MJH Life Sciences COVID-19 Coalition event focused on the treatment landscape, and the dual requests from Regeneron and Eli Lilly for emergency approval for their respective antibody treatments. 

Here’s a roundup of the latest coronavirus-related news:

Pharmacists Garner Priority COVID-19 Vaccination in New Recommendations​

The new National Academies of Sciences, Engineering, and Medicine's COVID-19 vaccine recommendations identify pharmacists as one of the essential groups that should be the first to receive the vaccines when they are available.

Read more​

Regeneron, Eli Lilly Both Request Emergency Approval for COVID-19 Antibody Therapies​

Both Regeneron and Eli Lilly have filed for emergency use authorization from the FDA for each of their investigational antibody therapies for the treatment of COVID-19.

Read more​

Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained​

On Tuesday, October 13, MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained” at 6 PM EDT.

Register for the webinar​

Election 2020: What Pharmacy Needs from the Next Administration​

Scope of practice and vaccination authority don’t usually grab much public attention. But when the US Department of Health & Human Services preempted state practice acts to allow all pharmacists to order and provide COVID-19 tests and provide routine pediatric immunizations, the profession hit the headlines. What happens next in health care depends largely on COVID-19, especially in light of the breaking news at press time that the President has been diagnosed with COVID-19. And then, of course, on the 2020 presidential election itself.

Read more​


Related to this article